Literature DB >> 8022529

Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor.

A Lucca1, V Lucini, M Catalano, M Alfano, E Smeraldi.   

Abstract

The molar ratio of total plasma tryptophan (Trp) to the sum of the other large neutral amino acids (LNAAs), thought to reflect brain serotonin (5-HT) formation, was estimated in 47 patients with major depression (unipolar and bipolar) before and after 6 weeks of treatment with a serotonin uptake inhibitor, fluvoxamine. We found a significant difference between responders (n = 39) and nonresponders (n = 8) for the pre- and in-treatment plasma Trp to LNAAs ratios. In contrast, there were no differences between the two groups for the mean plasma steady-state fluvoxamine levels. These findings suggest that a specific plasma amino acid profile may be a useful indicator of good clinical response to a selective 5-HT uptake inhibitor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8022529     DOI: 10.1159/000119071

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  6 in total

1.  Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response.

Authors:  M Maes; R Verkerk; E Vandoolaeghe; F Van Hunsel; H Neels; A Wauters; P Demedts; S Scharpé
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

2.  The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment.

Authors:  Allison B Gold; Nathan Herrmann; Walter Swardfager; Sandra E Black; Richard I Aviv; Gayla Tennen; Alexander Kiss; Krista L Lanctôt
Journal:  J Neuroinflammation       Date:  2011-02-16       Impact factor: 8.322

3.  Neural network analysis in pharmacogenetics of mood disorders.

Authors:  Alessandro Serretti; Enrico Smeraldi
Journal:  BMC Med Genet       Date:  2004-12-09       Impact factor: 2.103

4.  Metabolomics approach in the investigation of depression biomarkers in pharmacologically induced immune-related depression.

Authors:  Andreas Baranyi; Andreas Meinitzer; Hans-Bernd Rothenhäusler; Omid Amouzadeh-Ghadikolai; Dirk V Lewinski; Robert J Breitenecker; Markus Herrmann
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

5.  Disturbances in branched-chain amino acid profile and poor daily functioning in mildly depressed chronic obstructive pulmonary disease patients.

Authors:  Marisa R Pinson; Nicolaas E P Deutz; Rajesh Harrykissoon; Anthony J Zachria; Mariëlle P K J Engelen
Journal:  BMC Pulm Med       Date:  2021-11-07       Impact factor: 3.317

6.  Branched-Chain Amino Acids as New Biomarkers of Major Depression - A Novel Neurobiology of Mood Disorder.

Authors:  Andreas Baranyi; Omid Amouzadeh-Ghadikolai; Dirk von Lewinski; Hans-Bernd Rothenhäusler; Simon Theokas; Christoph Robier; Harald Mangge; Gerhard Reicht; Peter Hlade; Andreas Meinitzer
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.